glp-1 reimbursement news GLP-1s Are Busting Employer Budgets. Some Are Getting Creative to Lower Costs Recent Trends in GLP-1 Use

Victoza is approved for managing type 2 diabetes, while Saxenda is approved for chronic weight management

People who tap these blockbuster medications, which mimic a naturally produced hormone called GLP-1, lose an average of 15% to 20% of their body weight

WASHINGTON, D.C

Mouse models of diabetic nephropathy

Here, we report a successful desensitization protocol for the first time in two obese diabetic patients with an immediate hypersensitivity to exenatide

Late last month, reports said US regulators appeared likely to approve the $110 billion merger, following a meeting between Paramount CEO David Ellison and DOJ antitrust staffers